Emirates enhances vaccine transport capabilities to meet the growing demand


(MENAFN- Bangladesh Monitor) Dubai: Emirates SkyCargo, the freighter division of Emirates airline is further strengthening its temperature sensitive pharma and vaccine handling capabilities in Dubai with the extension of its fully automated cool room with 94 airline pallet positions at its pharma facility at Dubai International Airport.

The extended cool room will provide an additional 2600 square metres of temperature controlled environment (2-25 degrees Celsius) for the storage and handling of vaccines and other pharmaceuticals at Emirates SkyCargo’s purpose built GDP certified facility. The new extension can hold an estimated 60-90 million doses of COVID-19 vaccines at one time.

Emirates SkyCargo   has already transported over 75 million doses of COVID-19 vaccines on more than 250 flights to over 60 destinations since late 2020.

'We expect to reach the 100 million doses milestone well before the end of this month,” said Nabil Sultan, Emirates Divisional Senior Vice President, Cargo.

Emirates SkyCargo was one of the first air cargo carriers to begin extensive preparations during the early stages of the pandemic for the transportation of COVID-19 vaccines. It  set a dedicated GDP certified airside hub in Dubai for transporting COVID-19 vaccines. 

Emirates SkyCargo joined hands with DP World, International Humanitarian City and Dubai Airports to form the Dubai Vaccine Logistics Alliance aimed at rapidly transporting COVID-19 vaccines through Dubai to developing countries. It also signed an MoU with UNICEF to expedite the transportation of COVID-19 vaccines under the COVAX initiative.
 

MENAFN19062021000163011034ID1102307695


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.